| 5-R01-EB035498-02 |
A universal intranasal nanoengineered therapy against airborne RNA viruses |
Vinay Mahajan |
Brigham And Women'S Hospital |
| 5-R01-EB032865-04 |
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy |
Rihe Liu |
Univ of North Carolina Chapel Hill |
| 5-R01-EB033677-09 |
A “STICK” theranostic nanoplatform for image-guided drug delivery to brain malignancies |
Yuanpei Li |
University of California at Davis |
| 7-R01-EB027078-05 |
Active Drug Loading to Nanovesicles for Targeted Drug Delivery |
Zhenjia Wang |
State University of New York at Buffalo |
| 5-R01-EB035545-02 |
Artificial intelligence-integrated mechanistic modeling for rational design of nanoparticles to improve organ targeting and safety |
Prashant Dogra |
Methodist Hospital Research Institute |
| 7-R01-EB035545-03 |
Artificial intelligence-integrated mechanistic modeling for rational design of nanoparticles to improve organ targeting and safety |
Prashant Dogra |
University of Southern California |
| 5-R03-EB035643-02 |
Computational Modeling on the Interaction of Nanomedicine with Protein Corona and Its Impact on Tumor Delivery Efficiency |
Wei-Chun Chou |
University of California Riverside |
| 5-R01-EB025192-08 |
Defining the molecular interactions within nanoparticles that enable delivery of long nucleic acids |
Daniel Siegwart |
Ut Southwestern Medical Center |
| 5-R21-EB034465-03 |
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination |
Prabhani Atukorale |
University of Massachusetts Amherst |
| 5-R01-EB031022-04 |
Development of a web-based predictive model of nanoparticle delivery to tumors by integrating physiologically-based pharmacokinetic modeling with artificial intelligence |
Zhoumeng Lin |
University of Florida |
